Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

McGraw Hill Raises FY2026 Sales Guidance from $1.986B-$2.046B to $2.031B-$2.061B vs $2.017B Est

Author: Benzinga Newsdesk | November 12, 2025 07:27am

Fiscal Year 2026 Guidance

The following fiscal year 2026 guidance is forward-looking, and is based on the Company's current expectations. Actual results may differ materially from what is indicated below.

  Fiscal Year 2026 Guidance - Prior Fiscal Year 2026 Guidance - Updated
  As of August 14, 2025 As of November 12, 2025
($ in millions) Low High Low High
Revenue $1,986 $2,046 $2,031 $2,061
Re-occurring Revenue  1,477  1,517  1,504  1,524
Adjusted EBITDA (1)  663  703  702  722

Posted In: MH

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist